These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 17617652)

  • 1. Cisplatin nephropathy: is cytotoxicity avoidable?
    Razzaque MS
    Nephrol Dial Transplant; 2007 Aug; 22(8):2112-6. PubMed ID: 17617652
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of cisplatin nephrotoxicity: state of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer Care.
    Launay-Vacher V; Rey JB; Isnard-Bagnis C; Deray G; Daouphars M;
    Cancer Chemother Pharmacol; 2008 May; 61(6):903-9. PubMed ID: 18317762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse effects of cytotoxics-platinum agents.
    Selvaratnam G; Philips RH; Mohamed AK; Radzi A
    Adverse Drug React Toxicol Rev; 1997 Aug; 16(3):171-97. PubMed ID: 9512763
    [No Abstract]   [Full Text] [Related]  

  • 4. Sodium-wasting nephropathy caused by cisplatin in esophageal cancer.
    Abdelghani L; Modha K; Albaddawi E; Subramanian S
    J Support Oncol; 2008; 6(7):305-6. PubMed ID: 18847072
    [No Abstract]   [Full Text] [Related]  

  • 5. Extract of Prunus persica flesh (PPFE) improves chemotherapeutic efficacy and protects against nephrotoxicity in cisplatin-treated mice.
    Lee CK; Park KK; Hwang JK; Lee SK; Chung WY
    Phytother Res; 2009 Jul; 23(7):999-1005. PubMed ID: 19140122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How to keep kidneys safe while shrinking tumors: the conundrum of cisplatin action.
    Goligorsky MS
    Am J Physiol Renal Physiol; 2007 Jul; 293(1):F50-1. PubMed ID: 17507601
    [No Abstract]   [Full Text] [Related]  

  • 7. [Nephrotoxicity of antineoplastic drugs].
    Suzuki T; Nosaka K
    Ryoikibetsu Shokogun Shirizu; 1997; (16 Pt 1):542-6. PubMed ID: 9277811
    [No Abstract]   [Full Text] [Related]  

  • 8. Carbon monoxide: from silent killer to potential remedy.
    Hill-Kapturczak N; Agarwal A
    Am J Physiol Renal Physiol; 2006 Apr; 290(4):F787-8. PubMed ID: 16527924
    [No Abstract]   [Full Text] [Related]  

  • 9. Reduction of cisplatin-induced nephrotoxicity by pyrazolone compounds, derivatives of tetrahydroindazolonedicarboxylic acid.
    Marijic VF; Makarevic J; Stojkovic R; Kalinic L; Katalenic D; Radacic M
    Methods Find Exp Clin Pharmacol; 2008 Nov; 30(9):675-80. PubMed ID: 19229375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement activation in cisplatin nephropathy.
    Tamano M; Ohi H
    Nephron; 1999; 81(4):442-3. PubMed ID: 10095183
    [No Abstract]   [Full Text] [Related]  

  • 11. Nephrotoxicity of cancer treatment.
    Lydon J
    Oncol Nurs Forum; 1986; 13(2):68-77. PubMed ID: 3633578
    [No Abstract]   [Full Text] [Related]  

  • 12. Sildenafil attenuates renal injury in an experimental model of rat cisplatin-induced nephrotoxicity.
    Lee KW; Jeong JY; Lim BJ; Chang YK; Lee SJ; Na KR; Shin YT; Choi DE
    Toxicology; 2009 Mar; 257(3):137-43. PubMed ID: 19152827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatin: a review of toxicities and therapeutic applications.
    Barabas K; Milner R; Lurie D; Adin C
    Vet Comp Oncol; 2008 Mar; 6(1):1-18. PubMed ID: 19178659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity.
    Chirino YI; Pedraza-Chaverri J
    Exp Toxicol Pathol; 2009 May; 61(3):223-42. PubMed ID: 18986801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protect effect of bicyclol on cisplatin-induced nephrotoxicity in mice.
    Yu YN; Chen H; Li Y
    Arch Toxicol; 2009 Apr; 83(4):381-7. PubMed ID: 18956176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effects of vitamin C on cisplatin-induced renal damage: a light and electron microscopic study.
    Tarladacalisir YT; Kanter M; Uygun M
    Ren Fail; 2008; 30(1):1-8. PubMed ID: 18197536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of captopril against cisplatin-induced nephrotoxicity in rats.
    El-Sayed el-SM; Abd-Ellah MF; Attia SM
    Pak J Pharm Sci; 2008 Jul; 21(3):255-61. PubMed ID: 18614421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of cisplatin nephrotoxicity by probenecid.
    Daley-Yates PT; McBrien DC
    Cancer Treat Rep; 1984 Feb; 68(2):445-6. PubMed ID: 6538115
    [No Abstract]   [Full Text] [Related]  

  • 19. [Renal tolerability of cisplatin].
    Escudier B
    Rev Med Interne; 1996; 17(6):450-1. PubMed ID: 8758529
    [No Abstract]   [Full Text] [Related]  

  • 20. 5-Azacytidine prevents cisplatin induced nephrotoxicity and potentiates anticancer activity of cisplatin by involving inhibition of metallothionein, pAKT and DNMT1 expression in chemical induced cancer rats.
    Tikoo K; Ali IY; Gupta J; Gupta C
    Toxicol Lett; 2009 Dec; 191(2-3):158-66. PubMed ID: 19723570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.